Ductal Carcinoma in Situ of the Breast
March 2019 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Ductal Carcinoma in Situ of the Breast abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Ductal Carcinoma in Situ of the Breast. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Ductal Carcinoma in Situ of the Breast. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Ductal Carcinoma in Situ of the Breast every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:No Ink on Ductal Carcinoma In Situ: A Single Centre Experience.
Authors:Fregatti P, Gipponi M, Depaoli F, Murelli F, Guenzi M, Bonzano E, Ceppi M, Friedman D
Institution:Breast Surgery Unit, Ospedale Policlinico San Martino, Genoa, Italy. marco.gipponi@hsanmartino.it.
Journal:Anticancer Res. 2019 Jan;39(1):459-466. doi: 10.21873/anticanres.13134.

2:Breast conserving surgery with targeted intraoperative radiotherapy for the management of ductal carcinoma in situ.
Authors:Banks A, Coronado G, Zimmerman R, Iyengar G, Holmes DR
Institution:Department of Surgery, Helen Rey Breast Cancer Research Foundation, Los Angeles, California. California. Angeles, California. Monica, California. California.
Journal:J Surg Oncol. 2019 Mar;119(4):409-420. doi: 10.1002/jso.25347. Epub 2018 Dec 27.

3:Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
Authors:Kim JY, Kim JJ, Lee JW, Lee NK, Lee G, Kang T, Park H, Son YH, Grimm R
Institution:Department of Radiology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, 1-10, Ami-Dong, Seo-gu, Busan, 602-739, Republic of Korea. youdosa@naver.com.; Medical Research Institute, Pusan National University School of Medicine, Busan, Republic of Korea. youdosa@naver.com.; Busan Cancer Center, Pusan National University Hospital, Busan, Republic of Korea.; Siemens Healthineers, Seoul, Korea.; Siemens Healthineers, MR Application Predevelopment, Erlangen, Germany.
Journal:Eur Radiol. 2019 Feb;29(2):485-493. doi: 10.1007/s00330-018-5666-x. Epub 2018 Aug 2.

4:Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations.
Authors:Schwartzberg B, Lewin J, Abdelatif O, Bernard J, Bu-Ali H, Cawthorn S, Chen-Seetoo M, Feldman S, Govindarajulu S, Jones L, Juette A, Kavia S, Maganini R, Pain S, Shere M, Shriver C, Smith S, Valencia A, Whitacre E, Whitney R
Institution:Sarah Cannon Research Institute at Rose Medical Center, Denver, CO, USA. scmibs@gmail.com.
Journal:Ann Surg Oncol. 2018 Oct;25(10):2958-2964. doi: 10.1245/s10434-018-6623-2. Epub 2018 Jul 9.

5:American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.
Authors:DeSnyder SM, Hunt KK, Dong W, Smith BD, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci A
Institution:Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sgainer@mdanderson.org. Cancer Center, Houston, TX, USA. Houston, TX, USA. Center, Houston, TX, USA. Center, Houston, TX, USA. Houston, TX, USA. Cancer Center, Houston, TX, USA. Cancer Center, Houston, TX, USA.
Journal:Ann Surg Oncol. 2018 Oct;25(10):2965-2974. doi: 10.1245/s10434-018-6580-9. Epub 2018 Jul 9.

6:Estrogen-receptor status and risk of contralateral breast cancer following DCIS.
Authors:Stout NK, Cronin AM, Uno H, Ozanne EM, Hassett MJ, Frank ES, Greenberg CC, Punglia RS
Institution:Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA. Institute, Boston, MA, USA. Institute, Boston, MA, USA. USA. Institute, Boston, MA, USA. Cancer Institute, Boston, MA, USA. of Wisconsin School of Medicine, Madison, WI, USA.
Journal:Breast Cancer Res Treat. 2018 Oct;171(3):777-781. doi: 10.1007/s10549-018-4860-5. Epub 2018 Jun 26.

7:Surgeon Variability and Factors Predicting for Reoperation Following Breast-Conserving Surgery.
Authors:Valero MG, Mallory MA, Losk K, Tukenmez M, Hwang J, Camuso K, Bunnell C, King T, Golshan M
Institution:Department of Surgery, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. Institute, Boston, MA, USA. Institute, Boston, MA, USA. Institute, Boston, MA, USA. Institute, Boston, MA, USA. mgolshan@bwh.harvard.edu.
Journal:Ann Surg Oncol. 2018 Sep;25(9):2573-2578. doi: 10.1245/s10434-018-6526-2. Epub 2018 May 21.

8:Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program.
Authors:Elder K, Nickson C, Pattanasri M, Cooke S, Machalek D, Rose A, Mou A, Collins JP, Park A, De Boer R, Phillips C, Pridmore V, Farrugia H, Bruce Mann G
Institution:The Breast Service, Royal Melbourne and Royal Women's Hospital, Parkville, VIC, Australia. Global Health, The University of Melbourne, Parkville, VIC, Australia. Australia. Australia. Global Health, The University of Melbourne, Parkville, VIC, Australia. Australia. Australia. Australia. Australia. Australia. Australia. Australia. Bruce.mann@mh.org.au. Bruce.mann@mh.org.au.
Journal:Ann Surg Oncol. 2018 Sep;25(9):2563-2572. doi: 10.1245/s10434-018-6469-7. Epub 2018 May 1.

For a FREE PREVIEW of the Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast...
at a Special 20% Discount


Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast

Updated: January 2, 2019
167 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

DC23410406

Coupon Expires: July 18, 2019



What Our Customers Are Saying...

"The MediFocus Guidebook on DCIS was more than adequate for my research on this condition and I would recommend it to anyone wanting the "whole picture". Thank you for providing this excellent service."
C.M.
Los Angeles, California


"At a very difficult time, your MediFocus Guidebook on Ductal Carcinoma in Situ helped our family make informed decisions. Thank you for your help!"
M.A.L.
Metarie, Louisiana


"I was recently diagnosed with DCIS and was looking everywhere for information to get myself educated. The MediFocus Guidebook was very helpful in clarifying everything for me. The information is so well organized that it makes it easy to read and understand. I feel much better now that I've read this Guidebook and have a clearer understanding of the issues that I face. I highly recommend this Guidebook to anyone seeking to understand DCIS."
C.G.
Ft. Lauderdale, Florida



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2019 Medifocus, Inc. All rights reserved.